Furthermore, BCAR3 expression varies among breast cancer cell lines; it is found in lower amounts in less invasive ER-positive cell lines (MCF-7 and T47D), while more aggressive, metastatic ER-negative cell lines (MDA-MB-231 and BT549) exhibit moderate to high levels. Here, ESR1 is linked to breast cancer.